Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

LYCAONC

Lycia Therapeutics Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

LYCA

n/a

ONC

74/100

Quality

Is it a profitable, well-run business?

LYCA

n/a

ONC

4.6/10

Growth

Is the company growing?

LYCA

n/a

ONC

9.8/10

Valuation

Is the price reasonable? (higher = cheaper)

LYCA

n/a

ONC

3.4/10

Risk

How risky are the shares? (higher = lower risk)

LYCA

10.0/10

ONC

7.6/10

Momentum

Is the share price trending up?

LYCA

n/a

ONC

9.4/10

Financial strength

Is the balance sheet healthy?

LYCA

n/a

ONC

8.1/10

The balanced view

Model-generated

Lycia Therapeutics Inc.

There isn't enough financial data to give this stock a reliable overall score.

Leads on: risk

Best feature: relatively low risk (Beta (vs. market): 0.00)

Watch out: weakest area: risk profile (Beta (vs. market): 0.00)

BeOne Medicines AG

This company scores above average, with solid growth and a positive price trend, although its current valuation deserves attention.

Leads on: quality, growth, valuation, momentum, financial strength

Best feature: solid growth (Revenue growth (FY): 40.2%)

Watch out: valuation may be demanding (DCF upside: -1062.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.